…of a PCSK9 inhibitor. Place in lipid lowering therapy General treatment sequence High intensity statin therapy remains the foundation of lipid lowering treatment for patients…

…drugs have not been shown to improve long term cardiovascular outcomes in CCS. General strategy For most patients, initial therapy consists of a beta blocker…

…is generally: High intensity statin therapy at the highest tolerated dose. Addition of ezetimibe if the LDL C target is not achieved. Addition of a…

…mortality due to stopping statins. There are three main questions discussed in media, blogs and on social plattforms: Is high cholesterol a true cause of…

…the patient from sleep. Patients receiving modified antiplatelet therapy require clinical surveillance for both recurrent ischemia and bleeding. The source material does not specify a…

…rising potassium is usually more dangerous than a corresponding stable chronic value [4]. The grading must not be used mechanically. A patient with a plasma…

…Syncope is particularly important as a marker of potentially severe disease. The presence of haemodynamic instability places the patient in the high risk category and…

…be tailored to the patient's needs. Programming is done through an external device that communicates wirelessly with the pacemaker. A wide range of settings…

…to initiate or intensify preventive therapy is uncertain. Prevention guidelines support its use in selected individuals at intermediate risk, rather than as a universal population…

…Patients with manifest clinical disease are at high risk of progression and generally require all appropriate evidence based measures, including drug treatment and therapeutic lifestyle…